During the past decade, Virginia Cardiovascular Specialists conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Cardiovascular Specialists" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "AtriCure, Inc." with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "Atrium Medical Corporation" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Cardiovascular Specialists" #1 collaborator was "American College of Cardiology" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator and "University of Zurich" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Cardiovascular Specialists" are "Coronary Artery Disease" (3 trials), "Heart Failure" (3 trials), "Tachycardia, Ventricular" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "Virginia Cardiovascular Specialists" in a lesser frequency.

Most popular intervention types in "Virginia Cardiovascular Specialists" are "Device" (13 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead" (1 trials), "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials), "AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Cardiovascular Specialists" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Virginia Cardiovascular Specialists". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Virginia Cardiovascular Specialists, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Cardiovascular Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".